Rna Interference (Rnai)

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Washington University researchers solve piece of large-scale gene silencing mystery

Published December 4, 2008, 5:17 pm, SeedQuest

A team led by Craig Pikaard, Ph.D., Washington University in St. Louis professor of biology in Arts & Sciences, has made a breakthrough in understanding the phenomenon of nucleolar dominance, the silencing of an entire parental set of ribosomal RNA genes in a hybrid plant or animal.

Discover News | Full Story


Researchers solve piece of large-scale gene silencing mystery

Published December 4, 2008, 2:11 pm, PhysOrg

A team led by Craig Pikaard, Ph.D., WUSTL professor of biology in Arts & Sciences, has made a breakthrough in understanding the phenomenon of nucleolar dominance, the silencing of an entire parental set of ribosomal RNA genes in a hybrid plant or animal.

Discover News | Full Story


Researchers solve piece of large-scale gene silencing mystery

Published December 4, 2008, 2:03 pm, EurekAlert!

( Washington University in St. Louis ) A team led by Craig Pikaard, Ph.D., WUSTL professor of biology in arts and sciences, has made a breakthrough in understanding the phenomenon of nucleolar dominance, the silencing of an entire parental set of ribosomal RNA genes in a hybrid plant or animal. Since the machinery involved in nucleolar dominance is some of the same machinery that can go haywire ...

Discover News | Full Story


Researchers Make Key Discovery for Body to Accept Gene Therapy

Published December 4, 2008, 11:18 am, Newswise

Researchers at Columbia University Medical Center and the State University of New York at Stony Brook (SUNY) have developed a groundbreaking technique to sneak therapeutic genes past the body's defenses, possibly clearing one of the largest hurdles to realizing the potentials of medically altering a patient's DNA.

Discover News | Full Story


Next Generation RNAi Technology Discovered by AiRNA Pharmaceuticals and Boston Biomedical Published in Nature ...

Published December 4, 2008, 8:09 am, Business Wire via Yahoo! Finance

NORWOOD, Mass.----Boston Biomedical, Inc.:

Discover News | Full Story


Alnylam Selected as 2009 Technology Pioneer by the World Economic Forum

Published December 4, 2008, 6:47 am, Centre Daily Times

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has been selected as a 2009 Technology Pioneer by the World Economic Forum. Each year, the World Economic Forum awards companies from a variety of fields who have demonstrated visionary leadership and are involved in the development of a life-changing technology.

Discover News | Full Story


OPKO Health Announces Completion of Enrollment for Its Phase III Clinical Trial of Bevasiranib for Treatment of AMD

Published December 4, 2008, 6:16 am, Business Wire via Yahoo! Finance

MIAMI----OPKO Health, Inc. announced today that it has completed enrollment in the Company’s Phase III clinical trial of bevasiranib for the treatment of wet age-related macular degeneration .

Discover News | Full Story


Alnylam Selected as 2009 Technology Pioneer by the World Economic Forum

Published December 4, 2008, 6:08 am, Business Wire via Yahoo! Finance

CAMBRIDGE, Mass.----Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today that it has been selected as a 2009 Technology Pioneer by the World Economic Forum.

Discover News | Full Story


Intradigm expands RNAi therapeutics patent portfolio

Published December 4, 2008, 3:39 am, Pharmaceutical Business Review

Intradigm, a developer of targeted, systemic RNA interference therapeutics, has received a new US patent that claims methods of enhancing the RNA silencing activity of an RNAi agent through certain structural modifications in various cell types, including mammalian.

Discover News | Full Story


Next Generation RNAi Technology Discovered by AiRNA Pharmaceuticals and Boston Biomedical Published in Nature ...

Published December 3, 2008, 12:17 pm, Centre Daily Times

AiRNA Pharmaceuticals, Inc., a RNAi therapeutics company based on next generation proprietary RNAi technologies, and Boston Biomedical, Inc., a biotechnology company developing novel therapies targeting cancer stem cells, today announced that asymmetrical interfering RNA (aiRNA), a new fundamental RNAi technology discovered by the companies, is being published in the December issue of Nature ...

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a